0001446472-24-000002.txt : 20240426 0001446472-24-000002.hdr.sgml : 20240426 20240425180438 ACCESSION NUMBER: 0001446472-24-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240426 DATE AS OF CHANGE: 20240425 EFFECTIVENESS DATE: 20240426 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-PATH HOLDINGS, INC. CENTRAL INDEX KEY: 0001133818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870652870 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-511650 FILM NUMBER: 24877939 BUSINESS ADDRESS: STREET 1: 4710 BELLAIRE BOULEVARD STREET 2: SUITE 210 CITY: BELLAIRE STATE: TX ZIP: 77401 BUSINESS PHONE: (832) 742-1357 MAIL ADDRESS: STREET 1: 4710 BELLAIRE BOULEVARD STREET 2: SUITE 210 CITY: BELLAIRE STATE: TX ZIP: 77401 FORMER COMPANY: FORMER CONFORMED NAME: BIO-PATH HOLDINGS INC DATE OF NAME CHANGE: 20080221 FORMER COMPANY: FORMER CONFORMED NAME: OGDEN GOLF CO CORP DATE OF NAME CHANGE: 20010205 D 1 primary_doc.xml X0708 D LIVE 0001133818 BIO-PATH HOLDINGS, INC. 4710 BELLAIRE BOULEVARD SUITE 210 BELLAIRE TX TEXAS 77401 (832) 742-1357 DELAWARE BIO-PATH HOLDINGS INC OGDEN GOLF CO CORP Corporation true Peter H. Nielsen 4710 Bellaire Boulevard Suite 210 Bellaire TX TEXAS 77401 Executive Officer Director Heath W. Cleaver 4710 Bellaire Boulevard Suite 210 Bellaire TX TEXAS 77401 Director Paul D. Aubert 4710 Bellaire Boulevard Suite 210 Bellaire TX TEXAS 77401 Director Douglas P. Morris 4710 Bellaire Boulevard Suite 210 Bellaire TX TEXAS 77401 Director Aline Sherwood 4710 Bellaire Boulevard Suite 210 Bellaire TX TEXAS 77401 Director Biotechnology Decline to Disclose 06b false 2024-04-18 false true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 Park Avenue New York NY NEW YORK 10022 All States false 1275880 1275880 0 Includes warrants to purchase up to 375,000 shares of common stock and warrants to purchase up to 28,125 shares of common stock issued to H.C. Wainwright & Co., LLC ("HCW Warrants"), with an exercise price of $3.10 and $4.0313, respectively. false 3 102796 0 H.C. Wainwright & Co., LLC received the above sales commission and the HCW Warrants as consideration, in connection with a registered direct offering by the Issuer, which is not reported on this Form D. 0 true false BIO-PATH HOLDINGS, INC. /s/ Peter H. Nielsen Peter H. Nielsen President and Chief Executive Officer 2024-04-25